Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001663577-24-000211
Filing Date
2024-07-18
Accepted
2024-07-17 18:04:07
Documents
50
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K abti10k_033124.htm   iXBRL 10-K 1027261
7 GRAPHIC image_001.jpg GRAPHIC 2736
8 ex31_1.htm EX-31.1 9045
9 ex31_2.htm EX-31.2 9046
10 ex32_1.htm EX-32.1 5768
11 SETTLEMENT AGREEMENT AND RELEASE, DATED MARCH 12, 2024 ex10_5.htm EX-10.5 46491
12 GRAPHIC image_014.jpg GRAPHIC 3352
  Complete submission text file 0001663577-24-000211.txt   3818103

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE abti-20240331.xsd EX-101.SCH 30749
3 XBRL CALCULATION FILE abti-20240331_cal.xml EX-101.CAL 33274
4 XBRL DEFINITION FILE abti-20240331_def.xml EX-101.DEF 93763
5 XBRL LABEL FILE abti-20240331_lab.xml EX-101.LAB 198143
6 XBRL PRESENTATION FILE abti-20240331_pre.xml EX-101.PRE 171374
53 EXTRACTED XBRL INSTANCE DOCUMENT abti10k_033124_htm.xml XML 353208
Mailing Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR
Business Address 47 HAMILTON SQUARE BIRKENHEAD MERSEYSIDE X0 CH41 5AR 44 151 601 9477
ALTEROLA BIOTECH INC. (Filer) CIK: 0001442999 (see all company filings)

EIN.: 821317032 | Fiscal Year End: 0331
Type: 10-K | Act: 34 | File No.: 333-156091 | Film No.: 241123226
SIC: 2833 Medicinal Chemicals & Botanical Products
(CF Office: 03 Life Sciences)